VDR rs2228099: Understanding Your Vitamin D Receptor Variant
The rs2228099 variant is a common polymorphism located within the VDR gene, which encodes the vitamin D receptor. Research suggests this variant may influence how the body processes vitamin D, potentially impacting bone mineral density and calcium absorption.
What each genotype means
Common VDR variant profile
This genotype represents the most frequently observed sequence at this position in the VDR gene. Research into this variant explores its potential influence on how the body processes vitamin D and maintains bone mineral density, though findings are often mixed across different populations. Please discuss any concerns regarding bone health or vitamin D supplementation with your healthcare provider.
This is a common genotype found globally, though exact frequencies vary significantly by ancestral background.
Common VDR variant profile
This heterozygous genotype contains both the C and G alleles at this VDR location. Studies have investigated whether this variation contributes to differences in calcium absorption or bone mineral density, but results remain inconsistent and are not considered diagnostic. Consult with your clinician or pharmacist if you have questions about how your genetic profile might relate to your vitamin D status.
This genotype is frequently observed in diverse populations worldwide.
Common VDR variant profile
This genotype represents the alternative allele pairing at this VDR site. While some research has looked for associations between this variant and variations in bone mineral density or vitamin D response, the evidence is not definitive and varies by study population. Always consult with a medical professional before making changes to your diet or supplement regimen based on genetic information.
This genotype is common and found across many different ethnic and ancestral groups.
What is rs2228099?
The rs2228099 variant is a single nucleotide polymorphism (SNP) found within the VDR gene, which is located on chromosome 12. In the context of human genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is situated in a region of the gene that can influence the function or expression of the vitamin D receptor protein. Because the VDR gene is responsible for mediating the effects of vitamin D throughout the body, researchers have long investigated whether variations like rs2228099 contribute to differences in physiological traits. It is important to note that while this variant is frequently studied, it is just one of many genetic factors that interact with environmental influences, such as diet and sunlight exposure, to shape human health.
The Role of the VDR Gene
The VDR gene provides instructions for making the vitamin D receptor, a protein that acts as a transcription factor. Once activated by the active form of vitamin D (calcitriol), the receptor binds to specific regions of DNA to turn genes on or off. This process is essential for maintaining calcium homeostasis, which is critical for bone health, immune function, and cellular growth. By regulating the expression of genes involved in calcium absorption in the gut and bone remodeling, the VDR protein ensures that the body maintains the mineral balance necessary for strong skeletal structure. Because of its central role in these pathways, any genetic variation that alters the receptor's efficiency or stability is of significant interest to scientists studying metabolic and skeletal conditions.
Research and Evidence
Scientific literature has explored the association between VDR polymorphisms and various health outcomes, particularly bone mineral density (BMD) and calcium metabolism. While some studies have identified correlations between specific VDR variants and bone health, the evidence for rs2228099 is considered moderate. Research in this field often yields mixed results, as the impact of a single SNP can be subtle and highly dependent on the population being studied, dietary intake, and baseline vitamin D levels. It is common for initial findings in smaller cohorts to be difficult to replicate in larger, more diverse populations. Consequently, while rs2228099 is a recognized marker in genetic research, it is not currently used as a definitive diagnostic tool for predicting bone density or fracture risk in clinical practice.
What You Can Do With This Information
Understanding your genetic profile regarding the VDR gene can be an educational experience, but it should not be used to make medical decisions. Genetic variants are only one piece of a complex puzzle that includes your lifestyle, environment, and overall health history. If you are concerned about your bone health or vitamin D levels, the most effective approach is to consult with a healthcare professional. They can order appropriate blood tests to measure your actual vitamin D status and assess your bone density through clinical screenings. Never use genetic information to alter your medication or supplement regimen without first discussing it with your doctor or a licensed pharmacist, as they can provide guidance tailored to your specific health needs and clinical context.
How common is this variant?
The rs2228099 variant is considered a common polymorphism, with its genotype frequencies varying across different global ancestral populations.
Frequently asked questions
Does having a specific VDR genotype mean I have a vitamin D deficiency?
No, a genotype does not determine your current vitamin D levels. Vitamin D status is primarily influenced by environmental factors like sun exposure, diet, and supplementation, which can be measured through a blood test.
Can I use this genetic information to prevent osteoporosis?
Genetic information is not a substitute for clinical screening. Osteoporosis prevention is best managed through lifestyle choices like weight-bearing exercise and adequate nutrition, guided by a physician's assessment of your bone density.
Is rs2228099 the same as the FokI or TaqI variants?
No, rs2228099 is a distinct SNP within the VDR gene. While FokI and TaqI are also well-studied VDR polymorphisms, they represent different locations and variations within the gene sequence.
Should I change my vitamin D supplement dose based on my genotype?
You should never change your supplement dosage based on genetic results alone. Always consult with your doctor or pharmacist to determine the appropriate dosage based on your blood work and overall health status.
Sources & further reading
Educational information only, last refreshed 10/7/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2228099?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in VDR
Variant in the promoter region (Cdx2 site) of the vitamin D receptor gene associated with altered intestinal calcium absorption and bone mineral density.
This variant in the Vitamin D receptor gene is associated with susceptibility to Type 1 Diabetes and autoimmune thyroid disease.
Promoter polymorphism (Cdx2) in the VDR gene associated with bone mineral density and vitamin D metabolism.
Common polymorphism (TaqI variant) in the vitamin D receptor affecting mRNA stability and bone mineral density.
Known as the TaqI polymorphism, this variant is located in the 3' UTR of the VDR gene and is associated with altered mRNA stability, influencing vitamin D signaling, cancer cachexia susceptibility, and gastric cancer risk.
Variant in the VDR promoter (Cdx-2 binding site) associated with bone mineral density and calcium absorption efficiency.